A European research team designed customized heart valves with computer models, which when tested in sheep continued to perform in most cases for a year following implantation. . . . → Read More: Computer-Designed Heart Valves Operate Over Long Term
|
|||||
|
|
 One comment - (Comments are closed)  New products  biomedical, engineering, Europe, heart disease, life sciences, mathematics, medical device, patent, physical sciences, preclinical, software, stem cells, university 
A bioengineering lab developed a technique using common photography chips to measure blood flow in the brain, which could help detect traumatic brain injury, stroke, and related disorders. . . . → Read More: Technique Devised to Monitor Blood Flow in Brain Comments are closed New products biomedical, engineering, life sciences, medical device, patent, physical sciences, physics, preclinical, semiconductors, university 
A vaccine to protect against peanut allergies, given as a nanoscale droplets suspended in a nasal spray, is shown to prevent allergic reactions in tests with lab mice sensitized to peanuts. . . . → Read More: Nasal Spray Vaccine Shown to Control Peanut Allergies Comments are closed New products biomedical, engineering, entrepreneurs, life sciences, nanotechnology, patent, pharmaceuticals, university An engineering lab demonstrates how polymer gels and ambient sunlight can provide a simple, inexpensive alternative to current complex and expensive technologies for desalinating or purifying drinking water. . . . → Read More: Hydrogel, Solar Power Provide Simple Water Purification Comments are closed New products biomedical, energy, engineering, materials science, nanotechnology, patent, physical sciences, solar, university A new enterprise is formed to develop treatments for cancer using donated T-cells from the immune system, rather than the patient’s own T-cells, engineered to attack cancer cells. . . . → Read More: New Company Acquires Off-the-Shelf T-Cell Cancer Therapies One comment - (Comments are closed) Finance, Intellectual property, Joint ventures/collaborations biomedical, biotechnology, cancer, entrepreneurs, equity, genomics, investment, licensing, life sciences, patent, pharmaceuticals, venture capital A bioengineering group created a process for producing a cough suppressant in the lab, usually derived from opium poppies, but instead from genetically modified brewer’s yeast. . . . → Read More: Cough Suppressant Produced from Engineered Yeast Cells Comments are closed Intellectual property, New products biomedical, biotechnology, cancer, engineering, entrepreneurs, genomics, grant, licensing, life sciences, NIH, NSF, patent, pharmaceuticals, university A delivery technology for therapeutic compounds in nanoscale natural oil particles received a U.S. patent, which the company owning the technology says can be applied to drugs, nutritional supplements, and cannabis-based treatments. . . . → Read More: Patent Awarded for Nanoparticle Drug, Cannabis Delivery One comment - (Comments are closed) Intellectual property biomedical, chemistry, engineering, licensing, life sciences, materials science, nanotechnology, patent, pharmaceuticals, physical sciences, USPTO A bioengineering lab at Harvard University designed a refinement for genome editing to identify and remove small genetic mutations that can lead to diseases or organisms resistant to current drugs. . . . → Read More: Crispr Enhanced to Find, Edit Tiny Mutations Comments are closed New products biomedical, biotechnology, engineering, genomics, life sciences, medical device, patent, pharmaceuticals, university A smartphone-based system and app were shown in a pilot study with human subjects to measure a person’s blood pressure with about the same accuracy as some cuff devices normally used to gauge blood pressure. . . . → Read More: Smartphone App, Device Shown to Measure Blood Pressure 2 comments - (Comments are closed) New products biomedical, engineering, heart disease, licensing, life sciences, mathematics, medical device, patent, physical sciences, software, university U.S. patents were awarded to a biotechnology company developing therapies using the genomic editing process known as Crispr to create immune system cells with proteins for attacking cancer cells. . . . → Read More: Patents Awarded for Genetic Editing of CAR T-Cells Comments are closed Intellectual property biomedical, biotechnology, cancer, clinical trials, Europe, genomics, life sciences, patent, pharmaceuticals, USPTO |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
|||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
